Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Hemispherx Biopharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Hemispherx Biopharma Inc (HEB-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 12 $25.00

Wright Investors Service Comprehensive Report for Hemispherx Biopharma, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 May 2016 Wright Reports 56 $75.00

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review Summary Hemispherx Biopharma, Inc. (Hemispher...

09 May 2016 GlobalData 60 $300.00

Hemispherx BioPharma

07 May 2016 S&P Capital IQ Quantitative Report 9 $104.00

HEMISPHERX BIOPHARMA INC (HEB=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

07 May 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Hemispherx Biopharma Inc (HEB-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

06 May 2016 Thomson Reuters Stock Report 12 $25.00

HEB: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

06 May 2016 New Constructs, LLC 10 $25.00

Value Graph: HEMISPHERX BIO -- HEB

06 May 2016 Ford Investor Services, Inc. 1 $12.00

Will Hemispherx BioPharma, Inc Perform for Long-Term Investors?

10 Mar 2016 Sadif Analytics Prime 12 $25.00